key: cord-1047907-7tng7twi authors: Caruana, G.; Lebrun, L.-L.; Aebischer, O.; Opota, O.; Urbano, L.; DeRham, M.; Marchetti, O.; Greub, G. title: The dark side of SARS-CoV-2 rapid antigen testing: screening asymptomatic patients. date: 2021-04-27 journal: nan DOI: 10.1101/2021.04.24.21256040 sha: d9f35f72073b80ee74733b63da88e7e351e9da87 doc_id: 1047907 cord_uid: 7tng7twi Most of the reports describing SARS-CoV-2 rapid antigen tests (RATs) performances derive from COVID-19 symptomatic subjects in outpatient settings during periods of highest incidence of infections and high rates of hospital admissions. Here we investigated the role of RATs in an Emergency Department, as a screening tool before admission for COVID-19 asymptomatic patients. Each patient was screened with two simultaneous nasopharyngeal swabs: one immediately analyzed at the bedside using RAT and the other sent to the laboratory for RT-PCR analysis. A total of 116 patients were screened at hospital admission in a 250-bed community hospital in Morges (EHC), Switzerland. With a disease prevalence of 6% based on RT-PCR results, RAT detected only two out of seven RT-PCR positive patients (sensitivity 28.6%) and delivered two false positive results (specificity 98.2%), thus resulting not fiable enough to be used as a screening method in this clinical scenario. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. In October 2020 Switzerland faced a massive second wave, with up to 1800 59 infections in 14 days/100.000 inhabitants 3 , representing one of the world's highest rate 60 at that period. To meet the urgent need for rapid diagnosis immediately followed by 61 quarantine and contact tracing, a key tool for optimal management of epidemics, the 62 Swiss Federal Office of Public Health (FOPH) authorized the use of rapid antigen tests 63 (RATs) in addition to gold-standard RT-PCR 4 . Several reports describe RAT performances, most of them derived from COVID-65 19 symptomatic subjects in outpatient settings during periods of highest incidence of 66 infections and high rates of hospital admissions 5,6 . To date, more data are needed to 67 clarify the role of RAT as a screening tool among patients admitted to hospital 68 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The authors did not receive any financial support for this work. All authors had 108 full access to all the data in the study and they accept responsibility to submit for 109 publication. Table 1 ). As compared to RT-PCR, RAT detected two out of seven SARS-CoV-2 positive 117 patients and delivered two false-positive results, exhibiting a sensitivity of 28.6% and 118 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. 143 All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 On the other hand, the data gathered so far showed a clinically relevant difference 144 between RAT diagnostic performances in symptomatic and asymptomatic patients, Study data are not publically available but they will be shared upon request for the peer- (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 This article was prepared according to STANDARD guidelines for diagnostic ac- (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. RAT detected less than one third (2/7, 28.6%) of asymptomatic hospitalized patients, 184 who resulted positive by RT-PCR. b One out of 7 RT-PCR positive patients (also tested 185 positive with RAT) had a viral load at the limit of detection, that was not-quantifiable. All rights reserved. No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021 ECDC. COVID-19 situation update worldwide, as of week 2 2021. Evolution of trends 198 in 14-day COVID-10 cases and death notification rates by country and continent or 199 region Antigen rapid tests, nasopharyngeal 205 PCR and saliva PCR to detect SARS-CoV-2: a prospective comparative clinical trial Evaluation of the Panbio Covid-19 rapid 208 antigen detection test device for the screening of patients with Covid-19 Clinical application of a rapid antigen test for the 211 detection of SARS-CoV-2 infection in symptomatic and asymptomatic patients 212 evaluated in the emergency department: A preliminary report No reuse allowed without permission. (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. The copyright holder for this preprint this version posted SARS-CoV-2 Antigen Rapid 214 Immunoassay for Diagnosis of COVID-19 in the Emergency Department. Biomarkers : 215 biochemical indicators of exposure, response, and susceptibility to chemicals ImplemeNting SARS-CoV-2 Rapid antigen 218 testing in the Emergency wArd of a Swiss univErsity hospital: the INCREASE study Comparison of SARS-CoV-2 RT-PCR on a 221 high-throughput molecular diagnostic platform and the cobas SARS-CoV-2 test for the 222 diagnostic of COVID-19 on various clinical samples All rights reserved. No reuse allowed without permission.(which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity.The copyright holder for this preprint this version posted April 27, 2021. ; https://doi.org/10.1101 https://doi.org/10. /2021